PSHG
Performance ShippingDAI scenario view
RankAlpha Sentiment CodexAI sentiment snapshot
AI commentary
This remains a low-conviction monitoring memo, not a strong directional call. The deterministic packet started with zero primary notes and no recent-news or social coverage; after primary-source checks, the evidence improved on asset, charter, and fleet facts, but the setup is still dominated by dilution/listing risk and thin external coverage. Primary disclosures support a profitable 2025 and visible charter backlog, yet the May 4, 2026 anchor price of $1.82 suggests the market is heavily discounting execution quality and common-share economics rather than ignoring the company entirely.
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
The 2024 Form 20-F says 1,423,912 Series C preferred shares were outstanding as of April 14, 2025 and convertible at $1.3576, with additional warrant overhang and a history of Nasdaq minimum-bid notices and reverse splits; that keeps the stock vulnerable to capital-markets pressure even if vessel operations stay profitable. [#20F-2025-04-16]
Management said 2025 results benefited from deliveries of P. Massport and P. Tokyo and that the third LR2 newbuilding was delivered in January 2026 under a five-year charter at $31,000 per day; the earlier Clearlake contracts covered three LR2 newbuilds at $31,000 per day with expected gross revenue of about $169.8 million over the firm period. If reported 2026 utilization and cash generation validate that backlog, the market could reassess the discount. [#6K-2026-03-04] [#PR-2024-03-12]
PSHG sold P. Yanbu for $39 million in March 2025 and announced the February 2026 sale of its oldest vessel, P. Sophia, for $35.65 million with mid-2026 delivery expected; management linked these moves to lowering fleet age and improving liquidity. The company also signed contracts in March 2026 for two 158,000 DWT Suezmax newbuilds due in October 2028 and May 2029 at $81.5 million each, extending growth optionality but also extending execution risk. [#PR-2025-03-24] [#6K-2026-02-17] [#6K-2026-03-02]
Recommendation
No formal recommendation provided.

